Previous 10 | Next 10 |
While Aphria's stock price is down significantly in the past year, it has fared far better than its competitors. Overreaction to 2020 Q1 earnings provide long-term investors with attractive entry prices. On a P/S, P/B, EV/Sales, and EV/EBITDA basis, Aphria trades at a discount rel...
Canadian marijuana company Aphria (NASDAQ: APHA) is often viewed as a (relatively) safe pot stock pick. Aphria's peers, including Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC) , have recently gone on acquisition and expansion sprees, scaring some in...
The growing legalisation of medical cannabis is to bring total U.S. legal medical and adult-use cannabis market to $35B by 2025, according to the latest report of New Frontier Data.In the US, medical cannabis is now legal in 33 states and recreational cannabis in 10, with 5 addition...
Aphria (APHA) reported earnings last week and missed analyst expectations. This resulted in a strong drop in price, but Aaron thinks investors might not be seeing the whole picture. Read more to get his current thoughts on the company. Aphria (APHA ) reported its latest financial re...
Aphria struggled to hit its FQ1 financial targets despite an industry leading EBITDA total. The company expects to reach FCF positive levels in FQ3 with capital spending cuts and reduced production. The stock trades at ~15x forward EBITDA targets, but the market lacks confidence i...
An ongoing dispute between a cannabis investment company and a group of shareholders demanding changes to the firm’s board of directors has erupted once again. Meanwhile, the CEO of a Canadian producer asked the market what more his firm could offer to show growth as the comp...
Joe Biden has been preaching the need to take action to address climate change, criminal justice reform, and the importance of increasing access to healthcare. He has outlined several plans regarding these issues. If elected, Biden’s expected stimulus plans and restructuring meas...
Cantor Fitzgerald keeps an Overweight rating on Aphria (APHA) after taking in yesterday's earnings report and share price drop."Aphria in the Aug qtr continued to gain share and kept its #1 position in the Canadian rec market, but sales estimates came in below consensus in part due to shipmen...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Moment of truth for Brexit tradeBritish Prime Minister Boris Johnson is due to make a final call on whether to accept a narrow post-Brexit trade deal with ...
Aphria (NASDAQ: APHA) didn't exactly provide a high for its investors on Thursday. The Canada-based marijuana company released fiscal 2021 first-quarter results that were full of red ink and substantially worse than analyst expectations. For the quarter, Aphria's net revenue was...
News, Short Squeeze, Breakout and More Instantly...
Cannabis Industry Merger And Acquisitions In 2021 Many cannabis stocks have over the last several months been hit with a loss in trading momentum. This has led to many of the top cannabis stocks trading at lower prices. Yet so far in May pot stocks have been performing a bit more vo...